Discover 3,075 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,075
First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging
for
Endocrine Neoplasia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05335811
Phase1, Recruiting
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
for
Immune Checkpoint Therapy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06337097
Recruiting
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
for
Ovarian Cancer, Solid Tumor
Location: Houston TX, San Antonio TX, Oklahoma City OK, Denver CO,
Sponsor: OnCusp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06234423
Phase1, Recruiting
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
for
Follicular Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06043323
Phase2, Recruiting
Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies
for
Hematopoietic and Lymphoid Cell Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04888338
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Houston TX, San Antonio TX, Dallas TX, McAllen TX,
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All
Age: 18+
Code: NCT05440708
Phase1, Phase2, Recruiting
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
for
Lung Carcinoma
Location: Houston TX, Jackson MS, Memphis TN, Newnan GA, Tampa FL,
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06196008
Recruiting
A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
for
B Cell Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06213311
Phase2, Recruiting
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
for
Familial Adenomatous Polyposis
Location: Houston TX, Dallas TX, Nashville TN, St Louis MO,
Sponsor: Recursion Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT05552755
Phase1, Phase2, Recruiting
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
for
Breast Atypical Ductal Hyperplasia,
Location: Houston TX, Kansas City KS, St Louis MO, Charleston SC,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18 - 55
Code: NCT06184750
Phase2, Recruiting
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
for
Chronic Myelogenous Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT00816114
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Houston TX, Sugar Land TX, Webster TX, League City TX,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
for
Merkel Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05100095
Phase2, Recruiting
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Houston TX, Madison WI, Los Angeles CA, New Haven CT,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase1, Recruiting
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
for
Cervical Large Cell Neuroendocrine Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT04723095
Recruiting
Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
for
Ovarian Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT05636111
Phase1, Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
for
Multiple Myeloma
Location: Houston TX, Louisville KY, Denver CO, Charlotte NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05828511
Phase1, Phase2, Recruiting
Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect